This requires Flash to play. Click here to download.
Choose 1 of 4 patient responses from a clinical trial with ZOLINZA. View patient responses at baseline, week 21 and week 53.
Patient 1 stage at baseline: IVB sézary syndrome
Patient 2 stage at baseline: IIB mycosis fungoides
Patient 3 stage at baseline: IVA mycosis fungoides
Patient 4 stage at baseline: IVA sézary syndrome
*Sample responses during treatment with ZOLINZA for sézary syndrome and mycosis fungoides: In the pivotal trial, 30% (22/74, 95% CI [19.7% to 41.5%]) of patients experienced an objective response.
The information on this site is intended for health care professionals
in the United States and is not intended for the general public.
![Zolinza® [vorinostat] capsules Reactivate Expression](http://a248.e.akamai.net/7/248/430/20100305195528/www.zolinza.com/zolinza/shared/images/Logo_zolinza.gif)
This requires Flash to play. Click here to download.
Choose 1 of 4 patient responses from a clinical trial with ZOLINZA. View patient responses at baseline, week 21 and week 53.
Patient 1 stage at baseline: IVB sézary syndrome
Patient 2 stage at baseline: IIB mycosis fungoides
Patient 3 stage at baseline: IVA mycosis fungoides
Patient 4 stage at baseline: IVA sézary syndrome
*Sample responses during treatment with ZOLINZA for sézary syndrome and mycosis fungoides: In the pivotal trial, 30% (22/74, 95% CI [19.7% to 41.5%]) of patients experienced an objective response.
Open-label, single-agent, multicenter trial in patients (N=74) treated with ZOLINZA 400 mg once daily. Patients studied were aged 39 to 83 years (median 60 years); 48.6% female and 51.4% male; 82.4% white, 14.9% black, 1.4% Asian, and 1.4% other.
Objective response (primary end point)=either complete clinical response (CCR), defined as no evidence of disease, or partial response (PR), defined as a ≥50% decrease in SWAT skin assessment score compared with baseline. Both CCR and PR had to be maintained for at least 4 weeks.
Before prescribing ZOLINZA, please read the physician Prescribing Information. The Patient Information also is available.